Publications

Find at Harvard

August 2001 (Revised April 2002)
Case

Strategic Capital Management, LLC (A)

By: Mark L. Mitchell, Erik Stafford and Todd Pulvino

Strategic Capital Management, LLC, is a hedge fund that is planning to make financial investments in Creative Computers and Ubid. Creative Computers recently sold approximately 20% of its Internet auction subsidiary, Ubid, to the public at $15 per share. Ubid's stock... View Details

Keywords: Risk and Uncertainty; Business Subsidiaries; Internet and the Web; Investment Funds; Price; Performance Efficiency; Capital Markets; Auctions; Investment Return; Equity; Planning; Financial Services Industry

Research Summary

Analyst Disagreement, Mispricing and Liquidity (with Ronnie Sadka)

We document a close link between mispricing and liquidity by investigating stocks with high analyst disagreement. Previous research finds that these stocks tend to be overpriced, but prices correct down as uncertainty about earnings is resolved. We conjecture that one... View Details

June 2015 (Revised May 2017)
Case

LOYAL3: Own What You Love™

By: Luis M. Viceira and Allison M. Ciechanover

This case features San Francisco–based financial technology startup, LOYAL3. Founded in 2008, the company seeks to disrupt the capital markets and democratize access to those markets for retail investors. By the fall of 2014, LOYAL3 had three products. In the first,... View Details

Keywords: Capital Markets; Stocks; Strategic Planning

05 Jul 2006
Working Paper Summaries

Advertising and Expectations: The Effectiveness of Pre-Release Advertising for Motion Pictures

Keywords: by Anita Elberse & Bharat N. Anand; Entertainment & Recreation; Advertising; Motion Pictures & Video

February 2018 (Revised October 2024)
Case

Hikma Pharmaceuticals Governance Journey

By: Lynn Paine, Suraj Srinivasan and Gamze Yucaoglu

The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company’s 2017 AGM and reflecting on changes made over the previous year to address concerns expressed by proxy advisors and some... View Details

Keywords: Jordan; Emerging Markets; Private Sector; For-profit Firms; Boards Of Directors; Pharmaceuticals; Remuneration; Shareholder Engagement; Corporate Governance; Governing and Advisory Boards; Business and Shareholder Relations; Executive Compensation; Business Growth and Maturation; Pharmaceutical Industry; Jordan

Research Summary

Mark Bradshaw examines how sell-side financial analysts incorporate accounting information in their earnings forecasts, common stock valuations, and investment recommendations. In addition, he analyzes management reporting of modified GAAP earnings figures to... View Details

06 Apr 2017
HBS Seminar

Arkadiy Sakhartov, Wharton, University of Pennsylvania

January 2015
Article

X-CAPM: An Extrapolative Capital Asset Pricing Model

By: Nicholas Barberis, Robin Greenwood, Lawrence Jin and Andrei Shleifer

Survey evidence suggests that many investors form beliefs about future stock market returns by extrapolating past returns. Such beliefs are hard to reconcile with existing models of the aggregate stock market. We study a consumption-based asset pricing model in which... View Details

Keywords: Capital Asset Pricing; Returns; Investing; Asset Pricing; Investment Return

Find at Harvard

08 Sep 2003
Research & Ideas

A Bold Proposal for Investment Reform

critical look at companies' financial statements. Stock exchanges could fund the cost of audits through a modest transactions charge. Q: In your article you argue that the availability of high quality information is crucial to an... View Details

Keywords: by Ann Cullen; Financial Services

December 2014 (Revised November 2015)
Case

Alibaba Goes Public (A)

By: Krishna Palepu, Suraj Srinivasan, Charles C.Y. Wang and David Lane

In 2014 Alibaba debuted on the New York Stock Exchange, creating not only the largest IPO in history but this initial desire to list on the Hong Kong Stock Exchange was denied due to the company's desire to preserve its partner's control over decision rights. Why did... View Details

Keywords: Dual-class Share Structure; Alibaba; IPOs; VIE; Corporate Governance; Financial Services Industry; United States; Hong Kong; China

March 2023
Teaching Note

Hikma Pharmaceuticals Governance Journey

By: Suraj Srinivasan and Jonah Goldberg

Teaching Note for HBS Case No. 318108. The case opens with Said Darwazah, chairman and CEO of Hikma Pharmaceuticals, the multinational generics company, anticipating the company’s 2017 AGM and reflecting on changes made over the previous year to address concerns... View Details

Keywords: Jordan; Emerging Market; Private Sector; For-profit Firms; Boards Of Directors; Pharmaceuticals; Remuneration; Shareholder Engagement; Corporate Governance; Governing and Advisory Boards; Business and Shareholder Relations; Executive Compensation; Business Growth and Maturation; Pharmaceutical Industry; Jordan

23 Feb 2011
News

Low Risk, High Reward

2014
Article

Expectations of Returns and Expected Returns

By: Robin Greenwood and Andrei Shleifer

We analyze time-series of investor expectations of future stock market returns from six data sources between 1963 and 2011. The six measures of expectations are highly positively correlated with each other, as well as with past stock returns and with the level of the... View Details

Keywords: Performance Expectations; Investment Return

Find at Harvard

10 Nov 2011
News

Gauging Groupon’s Public Offering

March 1992 (Revised November 1993)
Case

Beta Management Co.

A manager of a small investment company has been successfully using index funds for limited market timing. Growth has allowed her to move into picking stocks. She is considering two small and highly variable listed stocks, but is concerned about the risk that these... View Details

Keywords: Risk and Uncertainty; Stocks; Financial Services Industry

29 Mar 2016
News

In Starwood Deal, Conventional Wisdom Upended

December 1994
Case

Alpha-Beta Technology, Inc. (B): Trials with Betafectin

This case follows the development of a firm's first product, the public presentation of research results, and the stock market reactions. In spite of successful research, the stock price falls dramatically. Asks why this happened, how concerned the CEO should be,... View Details

Keywords: Product Development; Biotechnology Industry

Forthcoming
Article

The Disappearing Index Effect

By: Robin Greenwood and Marco Sammon

The abnormal return associated with a stock being added to the S&P 500 has fallen from an average of 7.4% in the 1990s to 0.3% over the past decade. This has occurred despite a significant increase in the share of stock market assets linked to the index. A similar... View Details

Keywords: Stocks; Investment Return; Value

May 2020 (Revised November 2021)
Supplement

Valuing Peloton

By: E. Scott Mayfield

Peloton Interactive, a well-known unicorn in the connected fitness space, had gone public with a market capitalization of over $8.0 billion. In the weeks following its public debut, Peloton’s stock price fell by over 25%. Taylor Knox, a stock analyst and enthusiastic... View Details

Keywords: Business Model; Disruptive Innovation; Risk and Uncertainty; Stocks; Price; Valuation; Entertainment and Recreation Industry